Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lilia Cantero Aguilar"'
Autor:
Meriem Ladli, Cyrielle Richard, Lilia Cantero Aguilar, Sarah Ducamp, Sabrina Bondu, Pierre Sujobert, Jérôme Tamburini, Catherine Lacombe, Nabih Azar, Marc Foretz, Yael Zermati, Patrick Mayeux, Benoit Viollet, Frédérique Verdier
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
AMP-activated protein kinase (AMPK) is a heterotrimeric complex containing α, β, and γ subunits involved in maintaining integrity and survival of murine red blood cells. Indeed, Ampk α1−/−, Ampk β1−/− and Ampk γ1−/− mice develop hem
Externí odkaz:
https://doaj.org/article/a9a0e307e321463b82d48aac27127b72
Autor:
Eric Grignano, Lilia Cantero-Aguilar, Zubaidan Tuerdi, Thella Chabane, Romain Vazquez, Natacha Johnson, Rudy Birsen, Michaela Fontenay, Olivier Kosmider, Nicolas Chapuis, Didier Bouscary
Artemisinin is an anti-malarial drug that has shown anticancer properties. Recently, ferroptosis was reported to be induced by dihydroartemisinin and linked to iron increase. In the current study, we determined the effect of artemisinin in leukemic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdd406cc79aedc7b36b5f1aee6c9e662
https://doi.org/10.21203/rs.3.rs-1900883/v1
https://doi.org/10.21203/rs.3.rs-1900883/v1
Autor:
Frédérique Verdier, Catherine Lavazec, Patrick Mayeux, Lilia Cantero Aguilar, Carine Lefevre, Cyrielle Richard, Sophie Viret, Marjorie Leduc, El Hassan Faouzi, Nabih Azar
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (4), pp.480-492. ⟨10.1002/ajh.26104⟩
American Journal of Hematology, Wiley, 2021, 96 (4), pp.480-492. ⟨10.1002/ajh.26104⟩
Efficient erythropoiesis relies on the expression of the transferrin receptor type 2 (TFR2). In erythroid precursors, TFR2 facilitates the export of the erythropoietin receptor (EPOR) to cell surface, which ensures the survival and proliferation of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86dee1214ea28bfbbbdeab30dd0be0f
https://pubmed.ncbi.nlm.nih.gov/33476437
https://pubmed.ncbi.nlm.nih.gov/33476437
Autor:
Jean-Emmanuel Sarry, Patrick Mayeux, Jerome Tamburini, Nathan Guiraud, Justine Decroocq, Mathilde Gotanègre, Natacha Johnson, Olivier Kosmider, Tony Huynh, Eric Grignano, Rudy Birsen, Didier Bouscary, Lilia Cantero-Aguilar, Nicolas Chapuis, Michaela Fontenay, Clement Larrue
Publikováno v:
Haematologica. 107(2)
APR-246 is a promising new therapeutic agent that targets p53 mutated proteins in myelodysplastic syndromes and in acute myeloid leukemia (AML). APR-246 reactivates the transcriptional activity of p53 mutants by facilitating their binding to DNA targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2ca0865df7993278db204318923271
https://pubmed.ncbi.nlm.nih.gov/33406814
https://pubmed.ncbi.nlm.nih.gov/33406814
Autor:
Eric Grignano, Mathilde Hunault, Tony Huynh, Maya Belhadj, Olivier Kosmider, Patrick Mayeux, Lamya Haddaoui, Lilia Cantero Aguilar, Rudy Birsen, Didier Bouscary, François Guillonneau, Michaela Fontenay, Nicolas Chapuis, Jerome Tamburini, Myriam Hormi
Publikováno v:
European journal of haematologyREFERENCES. 105(5)
Objectives Venetoclax combined with hypomethylating agents is a new therapeutic strategy frequently used for treating AML patients who are not eligible for conventional chemotherapy. However, high response rates are heterogeneous due to different mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a77eb5477b80070e37cda391ff8e14b
https://pubmed.ncbi.nlm.nih.gov/32659848
https://pubmed.ncbi.nlm.nih.gov/32659848
Autor:
Nabih Azar, Sarah Ducamp, Pierre Sujobert, Catherine Lacombe, Frédérique Verdier, Cyrielle Richard, Patrick Mayeux, Yael Zermati, Meriem Ladli, Marc Foretz, Sabrina Bondu, Lilia Cantero Aguilar, Benoit Viollet, Jerome Tamburini
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2019, 104 (5), pp.907-918. ⟨10.3324/haematol.2018.191403⟩
Haematologica, Ferrata Storti Foundation, 2019, 104 (5), pp.907-918. ⟨10.3324/haematol.2018.191403⟩
International audience; AMP-activated protein kinase (AMPK) is a heterotrimeric complex containing α, β, and γ subunits involved in maintaining integrity and survival of murine red blood cells. Indeed, Ampk α1-/- , Ampk β1-/- and Ampk γ1-/- mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9707f483a50a7f03c2f13031c4d50691
https://hal.archives-ouvertes.fr/hal-02348833/document
https://hal.archives-ouvertes.fr/hal-02348833/document
Autor:
Clarisse Berlioz-Torrent, Lilia Cantero-Aguilar, Magalie Longo, Flore Rozenberg, Igor Beitia Ortiz de Zarate
The use of endocytic pathways by viral glycoproteins is thought to play various functions during viral infection. We previously showed in transfection assays that herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) is transported from the cell su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e043c1984573b92313d86807c4547824
https://europepmc.org/articles/PMC2168835/
https://europepmc.org/articles/PMC2168835/
Autor:
Rudy Birsen, Clement Larrue, Justine Decroocq, Natacha Johnson, Nathan Guiraud, Mathilde Gotanegre, Lilia Cantero-Aguilar, Eric Grignano, Tony Huynh, Michaela Fontenay, Olivier Kosmider, Patrick Mayeux, Nicolas Chapuis, Jean Emmanuel Sarry, Jerome Tamburini, Didier Bouscary
Publikováno v:
Haematologica, Vol 107, Iss 2 (2021)
APR-246 is a promising new therapeutic agent that targets p53 mutated proteins in myelodysplastic syndromes and in acute myeloid leukemia (AML). APR-246 reactivates the transcriptional activity of p53 mutants by facilitating their binding to DNA targ
Externí odkaz:
https://doaj.org/article/450db381926d46e993daececdc3996e8